PR Newswire Clinical TrialsOriginal article
Epicyt Pharma reports positive results in first-in-human study of BAFA in patients following gastric bypass surgery
Phase 1positiveBAFAPositive
AI Analysis
Summary
Epicyt Pharma reported positive topline results from a Phase 1/2a first-in-human study of BAFA in patients following gastric bypass surgery for treatment of impaired intestinal calcium uptake.
Clinical Trial Data
Phase
1/2a
Outcome Details
positive topline results from Phase 1/2a first-in-human study
Importance:6/10
Sentiment:
0.70
Phase 1first-in-humanpositive resultsgastric bypasscalcium uptake
Related Companies
Read the original article
Published by PR Newswire Clinical Trials on September 8, 2026 8:17 AM